Evidence map›Paper›PMID 28598330›Full record

ArticleeLife2017

Analysis of SUMO1-conjugation at synapses.

James A Daniel, Benjamin H Cooper, Jorma J Palvimo, Fu-Ping Zhang, Nils Brose, Marilyn Tirard

Open access · goldAbstract read
In one paragraph

Article in eLife, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Editorial: Regulation of synaptic structure and function.Frontiers in molecular neuroscience · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Small ubiquitin-like modifier 2 (SUMO2) is critical for memory processes in mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  15. Article
  16. SUMOylation in α-Synuclein Homeostasis and Pathology.Frontiers in aging neuroscience · 2020
    Review
  17. Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  18. Super Resolution Microscopy of SUMO Proteins in Neurons.Frontiers in cellular neuroscience · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

James A DanielMax Planck Institute of Experimental Medicine, Molecular Neurobiology, Göttingen, Germany.ORCID 0000-0002-2781-4544
Benjamin H CooperMax Planck Institute of Experimental Medicine, Molecular Neurobiology, Göttingen, Germany.
Jorma J PalvimoInstitute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Fu-Ping ZhangInstitute of Biomedicine and Turku Center for Disease Modeling, University of Turku, Turku, Finland.
Nils BroseMax Planck Institute of Experimental Medicine, Molecular Neurobiology, Göttingen, Germany.
Marilyn TirardMax Planck Institute of Experimental Medicine, Molecular Neurobiology, Göttingen, Germany.ORCID 0000-0002-5669-9610
Max Planck Institute of Experimental Medicine · DEUniversity of Eastern Finland · FIUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SUMO1-conjugation of proteins at neuronal synapses is considered to be a major post-translational regulatory process in nerve cell and synapse function, but the published evidence for SUMO1-conjugation at synapses is contradictory. We employed multiple genetic mouse models for stringently controlled biochemical and immunostaining analyses of synaptic SUMO1-conjugation. By using a knock-in reporter mouse line expressing tagged SUMO1, we could not detect SUMO1-conjugation of seven previously proposed synaptic SUMO1-targets in the brain. Further, immunostaining of cultured neurons from wild-type and SUMO1 knock-out mice showed that anti-SUMO1 immunolabelling at synapses is non-specific. Our findings indicate that SUMO1-conjugation of synaptic proteins does not occur or is extremely rare and hence not detectable using current methodology. Based on our data, we discuss a set of experimental strategies and minimal consensus criteria for the validation of SUMOylation that can be applied to any SUMOylation substrate and SUMO isoform.

Indexed as

SumoylationAnimalsGene Knock-In TechniquesGene Knockout TechniquesMiceStaining and LabelingSUMO-1 ProteinSynapsesSUMO-1 ProteinmouseneuroscienceSUMO1 knock-inSUMO1 knock-outSUMOylationSynapse

Identifiers

PMID28598330
PMCPMC5493437
OpenAlexW2623771415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.